INTRODUCTION
============

Systemic hypertension has profound effects on both the structure and function of the microvasculature \[[@R1]\]. The presence of microvascular disease, specifically microvascular rarefaction, is thought to be a key pathological characteristic of hypertension \[[@R2]\]. Microvascular rarefaction in turn have been linked to cardiovascular disease \[[@R3]\], stroke, left ventricular failure, and nephropathy \[[@R4]\] seen in hypertension \[[@R5]\], and being also a possible target for treatment \[[@R6]\]. In addition, hypertension is a risk factor for major eye disease such as diabetic retinopathy \[[@R7]\], age-related macular degeneration \[[@R8]\] and glaucoma \[[@R9]\]. Despite the importance of the microcirculation in hypertension, it is technically challenging to conduct in-vivo clinical studies on the microcirculation \[[@R10]\].

The retinal vasculature, measuring 100--300 μm in diameter \[[@R11]\], offer a unique and easily accessible 'window' to study the health and disease of the human microcirculation. Previous studies have used computer algorithms to measure retinal arteriolar and venular diameter from digital fundus photographs \[[@R12]\]. Epidemiological data of more than 20 000 individuals has demonstrated that retinal arteriolar narrows, as blood pressure (BP) levels increase \[[@R13]\]. Studies have also reported relationship of retinal arteriolar narrowing with stroke \[[@R14]--[@R16]\], kidney disease \[[@R17],[@R18]\] and cardiovascular mortality \[[@R19],[@R20]\]. However, images obtained from this technology do not provide any information about the retinal capillary circulation, which is more representative of the entire microvascular network and includes capillaries that are 3.5--6 μm in diameter \[[@R11]\].

Recent advances in optical coherence tomographic angiography (OCT-A) \[[@R21]--[@R23]\] has allowed for fast, noninvasive assessment of the capillaries, and have been used to evaluate eye diseases such as glaucoma \[[@R24]--[@R26]\] and diabetic retinopathy \[[@R27],[@R28]\]. Microvascular imaging technology such as the OCT-A can provide information about the architectural organization of capillaries, whose changes in structures may be the earliest markers of ischemia/hypoxia, before arteriolar and venular changes. In diabetic patients, reduced retinal capillary density was associated with hyperlipidemia, smoking and renal impairment \[[@R27]\].

Given that the reduction of capillary density (also known as capillary rarefaction) is a hallmark of essential hypertension, we measured the retinal capillary density using OCT-A in adults with treated systemic hypertension and evaluated possible correlations with ambulatory BP and renal parameters. We hypothesized that individuals with higher BP or poorer kidney function will have reduced retinal capillary density.

METHODS
=======

Study participants
------------------

We conducted a prospectively planned observational cross-sectional study including 153 eyes from 77 from participants with essential hypertension enrolled in the Response of the Myocardium to Hypertrophic Conditions in the Adult Population (REMODEL; Response of the myocardium to hypertrophic conditions in the adult population; NCT02670031) \[[@R29]\]. Briefly, Asians with essential hypertension on antihypertensive medications, aged 18 years and older, were recruited from a tertiary cardiac centre and primary care clinics in Singapore, from January 2017 to October 2017. Participants with secondary causes of hypertension, any on-going unstable medical conditions, previously diagnosed significant coronary artery disease (defined as previous myocardial infarction, more than 70% coronary stenosis on invasive coronary angiography or positive cardiac stress tests), strokes, atrial fibrillation and women who are pregnant or breast feeding were excluded from the study.

Study was approved by the SingHealth Centralized Institutional Review Board, and conducted in accordance to the Declaration of Helsinki. Written informed consent was obtained from participants.

Examination procedures
----------------------

Detailed interviewer-administered questionnaire was used to collect demographic data, lifestyle risk factors, medical history and medication use. Ethnicities were set by the Singapore census \[[@R30]\]. 24-h ambulatory BP (SBP and DBP) were measured in all participants. Blood pressure was monitored using ambulatory blood pressure monitors (SpaceLabs 90217A; SpaceLabs Medical, Dee Why, Sydney, Australia) for 24 h. The device was put on by a trained research officer, average of 14 days before the eye examination. The monitors are programmed to take measurements at 20 min intervals from 0600 to 2200 h and the frequency is reduced to every 30 min after 2300 h. An appropriately sized blood pressure cuff, based on the circumference of the patient\'s upper arm, will be provided to the patient. Calibration is then performed by measuring at least one manual reading with the monitor to ensure the monitor is working. Of note, the ambulatory blood pressure monitors have been validated according to the British Hypertension Society \[[@R31]\]. Hypertensive patients were stratified into two groups: well controlled BP defined as SBP less than 140 mmHg and/or DBP less than 90 mmHg and poorly controlled BP defined as SBP at least 140 mmHg and/or DBP at least 90 mmHg. Hyperlipidemia was defined based on clinical history of elevated cholesterol or lipid-lowering medications. Participants' height was measured using a wall-mounted measuring tape, and weight was measured using a digital scale (SECA, model 782 2321009, Germany). BMI was calculated as body weight (in kilograms) divided by body height (in meters) squared. Smoking status was defined as those never smoked, current smokers and past smokers.

Blood and mid-stream urine samples were collected for analysis of serum creatinine and urine microalbumin/creatinine ratio (MCR). Bio-specimens were processed in an accredited laboratory at the Singapore General Hospital. eGFR (in l/min per 1.73 m^2^)was calculated from plasma creatinine using the recently developed Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation \[[@R32]\]. MCR was measured using immunoassay. Normal MCR range was 0.2--3.3 mg/mmol creatinine whilst values greater than 33.9 mg/mmol creatinine implied clinical albuminuria.

Ocular examinations
-------------------

Participants underwent a questionnaire regarding their ocular history (e.g. intraocular surgery or glaucoma). Intraocular pressure was measured using noncontact tonometry (Auto Non-Contact Tonometer, NT-3000; Nidek, Gamagori, Japan). Fundus photography and OCT-A were performed approximately 30 min after topical instillation of two drops of 1% tropicamide, given 5 min apart. Fundus photography was then performed using a retinal camera (Canon CR-DGi with a 10-DSLR back; Canon, Tokyo, Japan). Patients with eye diseases (e.g. glaucoma, vascular or nonvascular retinopathies, age-related macular degeneration) were not included in the study.

Optical coherence tomographic angiography
-----------------------------------------

The OCT-A imaging system provides a noninvasive method for visualizing the retinal vasculature (AngioVue; Optovue, Inc., Fremont, California, USA). The AngioVue OCT-A captures the dynamic motion of moving particles, such as red blood cells flowing in a blood vessel, and allows a high-resolution three-dimensional visualization of perfused vasculature \[[@R24]\]. The OCT-A characterizes vascular information at each retinal layers as an *en face* angiogram, a capillary density map (Fig. [1](#F1){ref-type="fig"}), and quantitatively as capillary density (percentage), calculated as the percentage area occupied by blood vessels with flowing erythrocytes in the selected region.

![Capillary density map of the macular region showing retinal microvasculature of participants with (a) poorly controlled blood pressure (less dense) and (b) well controlled blood pressure (more dense). (i) Capillary density extracted map with a circular (diameter of 1.0 mm centered on the fovea) measurement region defined. (ii) Capillary density color-coded map. (iii) Deep vascular plexus (slab boundary of 15--70 μm below the inner plexiform layer).](jhype-37-572-g001){#F1}

For this study, we used capillary density measurements within the macula, in scans with a 6.0 × 6.0 mm^2^ field of view centered on the fovea \[[@R24]\]. En face OCT angiograms with 304 × 304-pixel dimensions were produced by maximum decorrelation (i.e. flow) projection between the segmentation lines. Each scan was automatically segmented by the AngioVue software (version 2016.2.0.35) so as to visualize the superficial (SVP) and deep vascular plexuses (DVP). Capillary density was calculated in a circular region with a diameter of 1.0 mm centered on the fovea.

A trained grader masked to the participant characteristics reviewed the quality of all OCT-A scans. Poor quality scans were excluded from the analysis if one of the following criteria were met: poor clarity images; local weak signal caused by artifacts such as floaters; residual motion artifacts visible as irregular vessel patterns on the *en face* angiogram and scans with segmentation failure.

Of the 95 participants, we excluded participants with diabetes (*n* = 15) and eye disease (*n* = 1) and missing or poor quality OCT-A images (*n* = 2), leaving 77 participants for analysis (Fig. [2](#F2){ref-type="fig"}).

![Identification of study participants. Of the 77 participants with systemic hypertension, 18 (23%) had poorly controlled blood pressure despite use of antihypertensive medications.](jhype-37-572-g002){#F2}

Statistical analyses
--------------------

Primary outcome was retinal capillary density at SVP and DVP. Shapiro--Wilk test was used to assess the normality of the distribution of the continuous variables. To compare continuous variables between groups, an independent *t*-test was performed for normally distributed variables, whereas Kruskal--Wallis test was used for nonnormally distributed variables. Continuous variables that were normally distributed are presented as mean ± standard deviation whereas nonnormally distributed variables are presented as median \[interquartile range (IQR)\]. Chi-square test or Fisher\'s exact test were used for categorical variables. There is a moderate positive linear correlation between the right and left eyes for capillary density in the superficial (Pearson correlation coefficient, *r* = 0.43; *P* value \<0.001) as well as the deeper (*r* = 0.45; *P* value \<0.001) plexus of the fovea, however, they are far from being perfectly correlated. Hence, there are differences between both eyes within one patient. Using data from summary or one eye of each participant gives reduced power, whereas model considering eye as the unit of analysis with consideration of correlation between paired eyes have greater statistical power and allow maximal use of available data \[[@R33]\]. Hence, we have applied the generalized estimating equation approach, which gives us increased precision of estimation results while accounting for the correlation between fellow eyes \[[@R34],[@R35]\]. Associations between systemic factors (independent variables) with retinal capillary density (dependent variable) were assessed using linear regression models with generalized estimating equations. Data were analyzed with statistical software (STATA, version 13.1; StataCorp LP, College Station, Texas, USA).

RESULTS
=======

The clinical characteristics of the adults with systemic hypertension by BP levels are shown in Table [1](#T1){ref-type="table"}. The mean ± SD age of participants was 58 ± 9 years and 49% were women (*n* = 38). Persons with well controlled BP had lower levels of urine MCR and higher retinal capillary density at DVP than those with poorly controlled BP despite use of antihypertensive medications (*P* \< 0.05 each). Of note, there was no difference in the number and type of antihypertensive medications for both groups.

The association between BP and other systemic factors and retinal capillary density at DVP is shown in Table [2](#T2){ref-type="table"}. Univariate linear regression analysis showed that BP control, SBP, MAP and eGFR were associated with retinal capillary density (Model 1; Table [2](#T2){ref-type="table"}). We next adjusted for age and sex because age was significantly associated with retinal capillary density \[univariate model: *β* = −0.45; 95% confidence interval (CI) −0.70 to −0.20; *P* \< 0.001). Even though sex was not significantly associated with retinal capillary density (univariate model: *β* = −1.37; 95% CI −5.96 to 3.21; *P* = 0.557), it is plausible that sex may have a biological effect on retinal capillary density. Age and sex-adjusted showed that persons with poorly controlled BP had lower retinal capillary density (*β* = −6.03; 95% CI −11.63 to −0.43; *P* = 0.035; Model 2; Table [2](#T2){ref-type="table"}) compared with those with well controlled BP. Figure [1](#F1){ref-type="fig"} further illustrates the relation of BP control and retinal capillary density. In the age and sex-adjusted model, higher SBP (*β* = −0.22; 95% CI −0.40 to −0.03; *P* = 0.021), higher DBP (*β* = −0.31; 95% CI −0.56 to −0.06; *P* = 0.016) and higher MAP (*β* = −0.32; 95% CI −0.58 to −0.07; *P* = 0.012) were associated with lower retinal capillary density whereas eGFR (*β* = 1.24; 95% CI −7.04 to 9.53; *P* = 0.769; Model 2; Table [2](#T2){ref-type="table"}) was not associated with retinal capillary density. This is because CKD-EPI Creatinine Equation considered age in their equation when estimating GFR. Both creatinine and urine MCR were not associated with retinal capillary density, in either univariate or age-adjusted models.

In separate models that considered only for BP (either for BP control, SBP, DBP or MAP) and eGFR (Table [2](#T2){ref-type="table"}), retinal capillary density was related to BP control (*β* = −6.49, 95% CI −12.39 to −0.59; *P* = 0.031; Model 3), SBP (*β* = −0.23, 95% CI −0.44 to −0.02; *P* = 0.031; Model 4) and MAP (*β* = −0.30, 95% CI −0.59 to −0.02; *P* = 0.036) but not with DBP (*β* = −0.25, 95% CI −0.52 to 0.03; *P* = 0.080; Model 5). eGFR was associated with retinal capillary density (*P* \< 0.05; Models 3--5; Table [2](#T2){ref-type="table"}). In other words, persons with poorly controlled BP, higher SBP, higher MAP and lower eGFR had a sparser retinal capillary density. Figure [3](#F3){ref-type="fig"} further illustrates the association observed between higher SBP and lower eGFR with sparser retinal capillary density. There were significant associations between 24-h ambulatory SBP (*r* = −0.27; *P* = 0.001) and eGFR (*r* = 0.26; *P* = 0.002) with retinal capillary density with among participants with systemic hypertension at deep vascular plexus. Systemic factors were, however, not associated with retinal capillary density at SVP (all *P* \> 0.05; Table [3](#T3){ref-type="table"}).

![Scatterplot showing (a) negative correlation of retinal capillary density with 24-h ambulatory SBP and (b) positive correlation of retinal capillary density with estimated glomerular filtration rate among participants with systemic hypertension at deep vascular plexus. Pearson\'s correlation coefficients and *P* values shown indicate the strengths of the linear relationship between the variables.](jhype-37-572-g003){#F3}

DISCUSSION
==========

In this study, we describe the use of OCT-A on adults with treated systemic hypertension and examine the correlation of OCT-A measured capillary density with systemic vascular risk factors. We document changes in the retinal capillary microvasculature that are associated with ambulatory BP as well as eGFR. This highlights the potential role of OCT-A in detecting early microvascular changes for hypertension.

We report several significant findings that are important in advancing our understanding of the changes at the retinal capillary level with ambulatory BP and eGFR. We show that having poorly controlled BP, higher ambulatory BP and lower eGFR were associated with reduced DVP capillary density, suggesting that systemic risk factors could lead to retinal microcirculatory changes in the capillary network of hypertensive patients. This is in keeping with what had been published previously on larger retinal vessels: a correlation between the retinal arteriolar narrowing with increasing levels of BP \[[@R36]--[@R39]\] and renal dysfunction \[[@R40],[@R41]\]. Also, people with early diabetes have shown capillary rarefaction compared with healthy persons \[[@R42]\].

The mechanism underlying the relation between retinal capillary density and systemic hypertension is unclear based on the present data. However, it may be those with chronic hypertension develop atherosclerosis over time, where vessels become narrow with age \[[@R36]--[@R39]\], leading to increased resistance to blood flow as well as breakdown of retinal vascular autoregulation \[[@R43]\]. Studies using scanning laser Doppler flowmetry have indicated an increased retinal vascular resistance \[[@R44],[@R45]\] and reduction in retinal capillary density \[[@R46]\] in hypertensive patients compared with normotensive individuals \[[@R44],[@R45]\]. An increased resistance of the vasculature may impair blood flow. This slow blood flow may be reflected as nonperfusion on OCT-A. As OCT-A relies on change between consecutive retinal scans, it will detect flow only above a minimum threshold \[[@R47]\]. Regions that have flow below the slowest detectable flow would, therefore, be considered as nonperfusion using the OCT-A imaging technique. Therefore, microvascular rarefaction might present an interesting target for treatment. Indeed, retinal capillary rarefaction was shown to be reversible after antihypertensive therapy in hypertensive patients \[[@R48]\]. Although we have provided evidence to support retinal capillary nonperfusion as the cause of hypertension, this proposed mechanism has not yet been proven. Showing causality would require animal models of chronic hypertension and subsequent OCT-A imaging.

The presence of microvascular changes in the eye (reduced retinal capillary density using OCT-A) was independently associated with kidney function (lower eGFR levels). Such significance of changes in larger retinal vessels, that is, hypertensive retinopathy has long been seen in patients with renal disease \[[@R49]\]. This is in keeping with what had been published previously on larger retinal vessels: a correlation between the retinal arteriolar narrowing with renal dysfunction \[[@R40],[@R41]\], and chronic kidney disease \[[@R17],[@R18]\]. In addition, a recent study using scanning laser Doppler flowmetry reported patients with moderately severe chronic kidney disease showed retinal signs such as arteriolar hypertrophic remodeling and capillary rarefaction \[[@R50]\]. The retinal and renal circulations share similarities in terms of its anatomic and physiologic characteristics \[[@R51]\]. We can speculate that a sparser network of retinal capillaries, expression of microvascular rarefaction, may mirror similar alterations in the renal microcirculation. Future studies can harness the unique noninvasive OCT-A imaging of the retinal microvasculature and explore if it can truly provide an insight into hypertension status and its related damage in the kidney.

What is the immediate significance of these findings? Variables such as BP and eGFR can influence the retinal capillary density and should be accounted for in studies that characterize patients with eye diseases. Most eye-related studies have defined their control groups as individuals without eye diseases \[[@R24]--[@R28],[@R52],[@R53]\], except for one study, which further excluded participants if they had systemic vascular conditions, that is, diabetes, hypertension \[[@R26]\]. Clinical investigators when using the OCT-A to investigate the role of altered retinal microvasculature in eye diseases should either exclude individuals having systemic hypertension from the control cohort or statistically account for systemic vascular risks. Failure to account for systemic risk factors as potential confounders can bias study results and lead to erroneous conclusions.

Our data may explain the inconsistencies among studies examining the use of OCT in glaucoma detection \[[@R54],[@R55]\]. Some studies \[[@R55]\] have reported that the OCT-A had a superior diagnostic capability than conventional imaging tools at identifying individuals with glaucoma, whereas others failed to do so \[[@R54]\]. Discrepancies among studies are likely attributed to the systemic vascular profiles of patients included in the analysis, particularly among individuals with systemic hypertension, because higher BP could also reduce the retinal capillary density. As such, further studies with well defined controls are required and systemic blood pressure needs to be reported.

Our study may help shed new light on the role of systemic hypertension in glaucoma. There may be at least two reasons why patients with hypertension have a higher risk of glaucoma \[[@R56]\]. Firstly, we have previously reported in a prospective population-based study that the increase in BP was associated with an increase in eye pressure \[[@R57]\], a key risk factor in glaucoma. Secondly, persons with poorly controlled BP lose their retinal capillaries as a result of high BP, as supported by the current study. This is compatible with the hypothesis of a vascular component being involved in the pathogenesis of glaucoma \[[@R58]\]. As such microvascular retinal damage may be a contributing factor to the progressive loss of retinal ganglion cells with the disease. Although our findings do not directly indicate a beneficial effect of reduced BP on the risk of glaucoma, they are compatible with that possibility.

There are two main levels of capillary networks within the retina, which spread like a net of cobweb throughout the retina \[[@R11]\]. Changes of capillary density were found exclusively within the deeper layer and not the superficial layer, suggesting that systemic hypertension could affect one retinal vascular layer differently from the other. Other systemic vascular conditions such as diabetes demonstrated widespread changes in both vascular plexuses \[[@R27]\]. Bonnin *et al.*\[[@R59]\] have used OCT-A in normal individuals and reported different topographic organizations of the SVP and DVP. They have speculated that the different structural patterns of these two capillary plexuses may be related to their flow resistance and perfusion.

Study strengths and limitations
-------------------------------

Strengths of this study included the use of ambulatory BP monitoring as well as the availability of urine MCR and eGFR for objective measurements of renal function. Some limitations of this investigation warrant discussion. First, the reduced capillary density that we observed could be the result of either capillary dropout or very slow rates of blood flow within the perfused capillaries. The current OCT-A device visualizes capillaries by detecting motion contrast from blood flow. A vessel with very slow or absent flow below the detection threshold of the instrument will not be detected \[[@R47]\]. For this reason, the term 'capillary density' is used as a quantitative summary measure of the vascular structures detected that reflects the proportion of area occupied by flowing vessels. Also, the OCT-A technology is unable to determine the true extension of a vessel. An interesting approach may be the combination of OCT-A and adaptive optics \[[@R60]\]. Adaptive optics is an optoelectronic technology that enables in-vivo ultra-high resolution imaging of retinal small arteries in humans \[[@R61]\]. It provides ultra-high resolution of vessel morphology of a small region (1.2 × 1.2 mm). Using adaptive optics-OCT-A, the vessels of the entire retinal vasculature can be better differentiated, providing crucial information on vessel morphology as well as vessel dropout. Second, even though there was reduced capillary density among those with poorly controlled BP in this study using OCT-A, this was only a cross-sectional study. OCT-A was introduced recently and the follow-up study is ongoing. Another limitation of this study was the relatively small sample size, which limited the power for evaluating the effect of some possible confounding variables on the retinal capillary density. In our results, some persons with higher SBP showed reduced retinal capillary density, whereas others seemed to have normal retinal capillary density (Fig. [3](#F3){ref-type="fig"}). Our small sample size does not allow us to perform sub-group analysis to study the pharmacological effect of differing classes of BP-lowering drugs on changes in retinal capillary density. Prediabetes is known to affect the microvasculature/macrovasculature \[[@R62]\]. As all our participants did not have diabetes, recent HbA1c or fasting glucose measurements was not available in the electronic medical records. In future work, it will be interesting to examine their HbA1c or fasting glucose in relation to OCT-A parameters. Finally, we did not assess the repeatability of our measurements. However, the repeatability for the retinal capillary density measurements has been published previously and reported to be excellent \[[@R63]\].

In conclusion, we have demonstrated a relationship between retinal capillary density with ambulatory BP and eGFR in adults with treated systemic hypertension. Measurement of retinal microvasculature at capillary level, using the OCT-A, is a unique noninvasive tool that has the potential to study early microvascular changes because of hypertension. Further studies are warranted to evaluate the efficacy of retinal capillary density to be a novel biomarker in prognosticating the incidence and progression of microvascular complications associated with hypertension.
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###### 

Clinical characteristics of treated hypertensive participants, stratified by blood pressure control

                                                                                   Participants with poorly controlled blood pressure                      Participants with well controlled blood pressure                        *P* value
  -------------------------------------------------------------------------------- ----------------------------------------------------------------------- ----------------------------------------------------------------------- -----------------------------------------------
  Number of participants                                                           18                                                                      59                                                                      
  Number of eyes                                                                   36                                                                      117                                                                     
  Sex, female (%)                                                                  10 (56%)                                                                28 (47%)                                                                0.547[^a^](#TF1-1){ref-type="table-fn"}
  Ethnicity, Chinese (%)                                                           16 (89%)                                                                50 (85%)                                                                0.597[^a^](#TF1-1){ref-type="table-fn"}
  Smoking status, never (%)                                                        18 (100%)                                                               55 (93%)                                                                0.525[^a^](#TF1-1){ref-type="table-fn"}
  Hyperlipidemia (%)                                                               7 (39%)                                                                 27 (46%)                                                                0.607[^a^](#TF1-1){ref-type="table-fn"}
  Chronic kidney disease (%)                                                       1 (6%)                                                                  4 (7%)                                                                  0.668[^a^](#TF1-1){ref-type="table-fn"}
  Type of antihypertensive medications                                                                                                                                                                                             
   Beta blockers                                                                   3 (17%)                                                                 22 (37%)                                                                0.102[^a^](#TF1-1){ref-type="table-fn"}
   Calcium channel blockers                                                        12 (67%)                                                                29 (49%)                                                                0.192[^a^](#TF1-1){ref-type="table-fn"}
   Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers   7 (39%)                                                                 32 (54%)                                                                0.254[^a^](#TF1-1){ref-type="table-fn"}
   Others (diuretics, alpha 2 adrenergic agonist)                                  2 (11%)                                                                 9 (15%)                                                                 0.660[^a^](#TF1-1){ref-type="table-fn"}
  Numbers of antihypertensive medications                                                                                                                                                                                          
   One                                                                             12 (67%)                                                                33 (56%)                                                                
   Two                                                                             5 (28%)                                                                 18 (30%)                                                                0.767[^a^](#TF1-1){ref-type="table-fn"}
   Three or more                                                                   1 (5%)                                                                  8 (14%)                                                                 
  Mean ± SD / median (IQR)                                                                                                                                                                                                         
  Age (years)                                                                      59 ± 11                                                                 57 ± 8                                                                  0.445[^a^](#TF1-1){ref-type="table-fn"}
  BMI (kg/m^2^)                                                                    25.0 (23.1--27.6)                                                       26.2 (23.8--28.6)                                                       0.219[^a^](#TF1-1){ref-type="table-fn"}
  Ambulatory BP (mmHg)                                                                                                                                                                                                             
   SBP                                                                             148 ± 8                                                                 125 ± 9                                                                 **\<0.001**[^a^](#TF1-1){ref-type="table-fn"}
   DBP                                                                             87 ± 7                                                                  77 ± 7                                                                  **\<0.001**[^a^](#TF1-1){ref-type="table-fn"}
   Mean arterial pressure                                                          107 ± 5                                                                 93 ± 7                                                                  **\<0.001**[^a^](#TF1-1){ref-type="table-fn"}
  eGFR (ml/min per 1.73 m^2^)                                                      90.2 (86.7--95.7)                                                       92.4 (76.2--102.2)                                                      0.945[^a^](#TF1-1){ref-type="table-fn"}
  Creatinine (pmol/l)                                                              73 (58--86)                                                             70 (60--79)                                                             0.346[^a^](#TF1-1){ref-type="table-fn"}
  Urine MCR (mg/g)                                                                 1.6 (1.1--3.7)                                                          0.75 (0--2.7)                                                           **0.042**[^a^](#TF1-1){ref-type="table-fn"}
  Retinal capillary density (%)                                                                                                                                                                                                    
   Superficial vascular plexus                                                     Both eyes: 37.2 ± 5.6 Right eyes: 37.4 ± 5.5 Left eyes: 37.6 ± 5.5      Both eyes: 39.6 ± 5.3 Right eyes: 38.7 ± 5.8 Left eyes: 37.8 ± 6.1      0.355[^b^](#TF1-2){ref-type="table-fn"}
   Deep vascular plexus                                                            Both eyes: 27.2 ± 13.0 Right eyes: 26.3 ± 14.2 Left eyes: 25.4 ± 14.0   Both eyes: 34.7 ± 11.3 Right eyes: 32.7 ± 11.0 Left eyes: 33.9 ± 10.6   **0.039**[^b^](#TF1-2){ref-type="table-fn"}

BP, blood pressure; CI, confidence interval; eGFR, estimated glomerular filtration rate; MCR, microalbumin-to-creatinine ratio.

Data are number (%) or mean ± standard deviation (SD) or median (interquartile range), as appropriate.

^a^For individual-level analysis, test for differences between groups was based on independent *t* test for normally distributed continuous variables or Kruskal--Wallis for nonnormally distributed continuous variables and with chi-square tests or Fisher\'s exact test for categorical variables.

^b^For eye-level analysis, test for differences between groups was based on generalized estimating equation. Bold face indicates statistically significant *P* value.

###### 

Associations of systemic factors with retinal capillary density at deep vascular plexus (dependent variable) in treated hypertensive participants (*n* = 153 eyes)

                                Model 1     Model 2           Model 3     Model 4   Model 5                                                                                                                          
  ----------------------------- ----------- ----------------- ----------- --------- ----------------- ----------- ------- ----------------- ----------- ------- ---------------- ----------- ------- --------------- -----------
  BP control status                                                                                                                                                                                                  
   Well controlled BP           Reference   Reference         Reference                                                                                                                                              
   Poorly controlled BP         −6.36       −12.38 to −0.33   **0.039**   −6.03     −11.63 to −0.43   **0.035**   −6.49   −12.39 to −0.59   **0.031**   --      --               --          --      --              --
  Ambulatory BP (mmHg)                                                                                                                                                                                               
   SBP                          −0.24       −0.45 to −0.03    **0.024**   −0.22     −0.40 to −0.03    **0.021**                                         −0.23   −0.44 to −0.02   **0.031**                           
   DBP                          −0.21       −0.47 to 0.06     0.124       −0.31     −0.56 to −0.06    **0.016**                                         --      --               --          −0.25   −0.52 to 0.03   0.080
   Mean arterial pressure       −0.29       −0.57 to −0.01    **0.039**   −0.32     −0.58 to −0.07    **0.012**                                                                                                      
  eGFR (ml/min per 1.73 m^2^)   7.37        1.14--13.60       **0.020**   1.24      −7.04 to 9.53     0.769       7.64    2.45--12.85       **0.004**   6.42    1.25--11.60      **0.015**   8.44    2.13--14.75     **0.009**
  Creatinine                    −4.07       −10.58 to 2.43    0.220       −1.45     −10.22 to 7.33    0.746       --      --                --          --      --               --          --      --              --
  Urine MCR (mg/g)              0.77        −1.63 to 3.17     0.529       0.80      −1.09 to 2.69     0.406       --      --                --          --      --               --          --      --              --

BP, blood pressure; CI, confidence interval; eGFR, estimated glomerular filtration rate; MCR, microalbumin-to-creatinine ratio. Data were analyzed by the use of linear regression model with generalized estimating equation and presented as mean ± standard deviation or number (%), as appropriate. Bold face indicates statistically significant *P* value. Model 1: univariate; Model 2: adjusted for age and sex; Model 3: adjusted for eGFR and BP control status; model 4: adjusted for eGFR and SBP; Model 5: adjusted for eGFR DBP.

###### 

Associations of systemic factors with retinal capillary density at superficial vascular plexus (dependent variable) in treated hypertensive participants (*n* = 153 eyes)

                                Univariate model                   
  ----------------------------- ------------------ --------------- -------
  BP control status                                                
   Well controlled BP           Reference                          
   Poorly controlled BP         −1.13              −3.54 to 1.27   0.355
  Ambulatory BP (mmHg)                                             
   SBP                          −0.06              −0.16 to 0.03   0.193
   DBP                          −0.01              −0.12 to 0.11   0.895
   Mean arterial pressure       −0.05              −0.18 to 0.07   0.419
  eGFR (ml/min per 1.73 m^2^)   0.05               −0.01 to 0.11   0.064
  Urine MCR (mg/g)              0.32               −0.53 to 1.17   0.463

BP, blood pressure; CI, confidence interval; eGFR, estimated glomerular filtration rate; MCR, microalbumin-to-creatinine ratio. Data were analyzed by the use of linear regression model with generalized estimating equation and presented as mean ± standard deviation or number (%), as appropriate.
